OBJECTIVE: To analyse the genetic diversity of Plasmodium falciparum (P. falciparum) using msp-1 and msp-2 as antigenic markers. METHODS: Parasite DNA was extracted from 100 blood samples collected from P. falciparum-positive patients confirmed by microscopy, and followed by PCR-genotyping targeting the msp-1 (block2) and msp-2 (block 3) allelic families. RESULTS: All the families of msp-1 (K1, MAD20 and R033) and msp-2 (FC27 and 3D7) locus were observed. Results revealed that K1 (60/100) was the most predominant genotype of msp-1 allelic family followed by the genotypes of MAD20 (50/100) and R033 (45/100). In the msp-2 locus, FC27 genotype (62/100) showed higher frequency than 3D7 genotype (55/100). The allelic families were detected either alone or in combination with other families. However, no R033/MAD20 combination was observed. Multiplicity of infection (MOI) with msp-1 was higher in the locality of Ikorodu (1.50) than in Lekki (1.39). However, MOI with msp-2 was lower in the locality of Ikorodu (1.14) than in Lekki (1.76). There was no significant difference in the mean MOI between the two study areas (P=0.427). CONCLUSIONS: The observation of limited diversity of malaria parasites may imply that the use of antigenic markers as genotyping tools for distinguishing recrudescence and re-infections with P. falciparum during drug trials is subjective.
OBJECTIVE: To analyse the genetic diversity of Plasmodium falciparum (P. falciparum) using msp-1 and msp-2 as antigenic markers. METHODS: Parasite DNA was extracted from 100 blood samples collected from P. falciparum-positive patients confirmed by microscopy, and followed by PCR-genotyping targeting the msp-1 (block2) and msp-2 (block 3) allelic families. RESULTS: All the families of msp-1 (K1, MAD20 and R033) and msp-2 (FC27 and 3D7) locus were observed. Results revealed that K1 (60/100) was the most predominant genotype of msp-1 allelic family followed by the genotypes of MAD20 (50/100) and R033 (45/100). In the msp-2 locus, FC27 genotype (62/100) showed higher frequency than 3D7 genotype (55/100). The allelic families were detected either alone or in combination with other families. However, no R033/MAD20 combination was observed. Multiplicity of infection (MOI) with msp-1 was higher in the locality of Ikorodu (1.50) than in Lekki (1.39). However, MOI with msp-2 was lower in the locality of Ikorodu (1.14) than in Lekki (1.76). There was no significant difference in the mean MOI between the two study areas (P=0.427). CONCLUSIONS: The observation of limited diversity of malaria parasites may imply that the use of antigenic markers as genotyping tools for distinguishing recrudescence and re-infections with P. falciparum during drug trials is subjective.
Entities:
Keywords:
Antigenic markers; Diversity; Drug trials; Multiplicity of infections; Recrudescence
Authors: Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda Journal: N Engl J Med Date: 2008-12-08 Impact factor: 91.245
Authors: O K Amodu; R A Gbadegesin; S A Ralph; A A Adeyemo; P E C Brenchley; O O Ayoola; A E Orimadegun; A K Akinsola; P E Olumese; O O Omotade Journal: Acta Trop Date: 2005-09 Impact factor: 3.112
Authors: G I Olasehinde; C S Yah; R Singh; O Olusola Ojuronbge; A A Ajayi; N Valecha; A O Abolaji; A O Adeyeba Journal: Afr Health Sci Date: 2012-09 Impact factor: 0.927
Authors: S Viriyakosol; N Siripoon; C Petcharapirat; P Petcharapirat; W Jarra; S Thaithong; K N Brown; G Snounou Journal: Bull World Health Organ Date: 1995 Impact factor: 9.408
Authors: Daibin Zhong; Yaw Afrane; Andrew Githeko; Zhaoqing Yang; Liwang Cui; David M Menge; Emmanuel A Temu; Guiyun Yan Journal: Am J Trop Med Hyg Date: 2007-12 Impact factor: 2.345
Authors: Victor A Mobegi; Kovana M Loua; Ambroise D Ahouidi; Judith Satoguina; Davis C Nwakanma; Alfred Amambua-Ngwa; David J Conway Journal: Malar J Date: 2012-07-03 Impact factor: 2.979
Authors: Najia K Ghanchi; Andreas Mårtensson; Johan Ursing; Sana Jafri; Sándor Bereczky; Rabia Hussain; Mohammad A Beg Journal: Malar J Date: 2010-01-01 Impact factor: 2.979
Authors: Felix M Mulenge; Carol W Hunja; Esther Magiri; Richard Culleton; Akira Kaneko; Rashid A Aman Journal: Am J Trop Med Hyg Date: 2016-09-06 Impact factor: 2.345
Authors: Fehintola V Ajogbasile; Adeyemi T Kayode; Paul E Oluniyi; Kazeem O Akano; Jessica N Uwanibe; Benjamin B Adegboyega; Courage Philip; Oluwagboadurami G John; Philomena J Eromon; George Emechebe; Finimo Finimo; Nnenna Ogbulafor; Nma Jiya; Uche Okafor; Jose Ambe; Robinson D Wammanda; Stephen Oguche; Olugbenga A Mokuolu; Akintunde Sowunmi; Onikepe A Folarin; Christian T Happi Journal: Malar J Date: 2021-05-26 Impact factor: 2.979
Authors: Smita Das; Mbanga Muleba; Jennifer C Stevenson; Julia C Pringle; Douglas E Norris Journal: Parasit Vectors Date: 2017-01-26 Impact factor: 3.876
Authors: Muyiwa K Oyebola; Emmanuel T Idowu; Haddy Nyang; Yetunde A Olukosi; Olubunmi A Otubanjo; Davis C Nwakanma; Samson T Awolola; Alfred Amambua-Ngwa Journal: Malar J Date: 2014-12-13 Impact factor: 2.979
Authors: Mohd Ridzuan Mohd Abd Razak; Umi Rubiah Sastu; Nor Azrina Norahmad; Abass Abdul-Karim; Amirrudin Muhammad; Prem Kumar Muniandy; Jenarun Jelip; Christina Rundi; Mallika Imwong; Rose Nani Mudin; Noor Rain Abdullah Journal: PLoS One Date: 2016-03-29 Impact factor: 3.240
Authors: Olusola Ajibaye; Akinniyi A Osuntoki; Albert Ot Ebuehi; Bamidele A Iwalokun; Emmanuel O Balogun; Kathleen N Egbuna Journal: Adv Biomed Res Date: 2017-11-10